文章
醫療新知 > 抹茶可醫乳癌?英研究發現抹茶可令乳癌細胞休眠死去 / Could matcha green tea be used to treat cancer? ‘Striking’ results show it kills cancer cells by stopping them from refuelling

抹茶可醫乳癌?英研究發現抹茶可令乳癌細胞休眠死去 / Could matcha green tea be used to treat cancer? ‘Striking’ results show it kills cancer cells by stopping them from refuelling

03-09-2018

抹茶可醫乳癌?英研究發現抹茶可令乳癌細胞休眠死去
19:21 2018/09/02

 

英國一項研究發現,抹茶萃取物可破壞乳癌細胞。

 

乳癌是香港女性頭號癌症,一旦不幸患上乳癌,可能需切除乳房作出治療。日本人喜愛的抹茶是綠茶的一種,英國一項最新研究發現,抹茶的萃取物可破壞乳癌細胞,壓抑它們獲得能量,令乳癌細胞「休眠」然後死去,研究人員形容,抹茶深具「治療潛力」。

位於英國大曼徹斯特的索爾福德大學(University of Salford)研究團隊,早前已發現伯爵茶中的成分「佛手柑」,可殺死癌症幹細胞。今次再以抹茶針對乳癌幹細胞進行研究,結果發現抹茶萃取物,能夠抑制乳癌幹細胞內的線粒體(mitochondria)進行新陳代謝,最後讓癌細胞變得不活躍,繼而死亡。

另外,抹茶萃取物亦可削弱癌細胞當中的核糖體(ribosome)組成物,降低癌細胞製造蛋白質的能力。研究發表於科學期刊《Aging》上,研究人員認為研究結果令人期待,科學家亦積極找尋治療癌症的方式。

主導研究的利桑蒂教授(Professor Michael Lisanti)表示,抹茶是天然產品,若作為膳食補充劑,具有很大的治療潛力。

不過,英國癌症研究組織專家萊德威克(Martin Ledwick)指出,即使研究顯示抹茶可以殺死實驗室裡培養的乳癌細胞,但與喝茶有很大的不同,現在仍沒有證據顯示,抹茶對癌症有療效,尚待臨床測試驗證。

據香港癌症資料統計中心2017年公佈的數據顯示,乳癌由1993年起成為香港女性頭號癌症。在1993至2015年間,本港女性確診乳癌的個案增加三倍,由每年的1,152宗增至每年3,900宗,平均每天有10名女士確診。

 

Could matcha green tea be used to treat cancer? ‘Striking’ results show it kills cancer cells by stopping them from refuelling

  • Matcha tea has long been hailed as having several beneficial health properties

  • Lab trials have shown the bitter tasting tea can keep cancer stem cells dormant

  • Scientists assessed the effects of a matcha extract on breast cancer stem cells

 

It’s long been hailed as having beneficial health properties, such as aiding weight loss.

But matcha green tea could be used to treat cancer – not just shed the pounds from your stomach, according to new research.

Laboratory trials have revealed the bitter tasting tea can keep cancer cells dormant, by knocking out their energy supply, stopping them from ‘refuelling’.

University of Salford researchers have branded their results ‘striking’, as scientists continue to hunt down cures for cancer.

They assessed the effects of a matcha extract on breast cancer stem cells – which can transform into any tumour cell, divide and renew themselves.

 

Laboratory trials have revealed the bitter tea can keep cancer cells dormant, by knocking out their energy supply

 

The team delved into its effects by using metabolic phenotyping, a scientific process that examines how compounds directly impact cells.

Through that, they found matcha tea extract suppresses the metabolism of mitochondria, considered the powerhouse of each cell.

Professor Michael Lisanti, who led the study, revealed the extract had shifted the cancer cells towards a ‘quiescent metabolic state’.

He added: ‘In other words, it [matcha] is preventing the cells from “refuelling” and therefore they [cancer cells] become inactive and die.’

The results were published in the scientific journal Aging.

The researchers analysed how matcha strikes the cancer cells in hope of shining further light of its potential cancer-fighting properties.

They uncovered evidence it ‘strongly affected’ the mTOR signalling pathway, known to play a critical role in the metabolism of cancer cells.

The matcha extract also weakened components of a ribosome – which synthesise most of the proteins required by cells for their survival.

Matcha could, in the future, be used in the same way as rapamycin – a drug that switches off the mTOR pathway, the researchers hope.

Professor Lisanti added: ‘Matcha green tea is a natural product used as a dietary supplement with great potential for a range of treatments.

‘The effects on human breast cancer cells were very striking; the active ingredients in matcha having a surgical effect in knocking out certain signalling pathways.

‘Our results are consistent with the idea that matcha may have significant therapeutic potential, mediating the metabolic reprogramming of cancer cells.’

Professor Lisanti and colleagues have previously found that bergamot, the ingredient in Earl Grey tea, kills cancer stem cells.

Matcha is a type of green tea in a powdered form. It originates from Japan, where it’s best known for its use in tea ceremonies.

Martin Ledwick, Cancer Research UK’s head information nurse, said: ‘There is no strong evidence that green tea can help treat cancer in patients.

‘Although this early study shows that matcha green tea can kill breast cancer cells grown in the lab, this is very different to drinking the tea.

‘Other early stage research suggests that extracts from green tea could stop cancer cells from growing.

‘But at the moment the evidence is not strong enough to know this for sure and we need verification from human studies to prove this.’

 

WHAT IS MATCHA TEA?

Matcha tea is a type of green tea in a powdered form.

It originates from Japan, where it’s best known for its use in tea ceremonies.

Matcha, other green teas and regular (black) tea are actually made from the same plant – Camellia sinensis.

Most green teas are simply made by steaming fresh Camellia leaves, but making matcha tea involves a more complex process.

It’s made only from the fresh leaf tips.

The plants are shaded from the sun between the time when the new leaf shoots start to appear and when they are picked.

The shade is said to increase the content of chlorophyll and other nutrients, including the amino acid L-theanine (more on L-theanine below).

After picking the best leaves, they’re steamed, gently air-dried, and then ground into a fine powder, removing any fibres.

 

文章來自: Topick (中) / dailymail (Eng)

https://topick.hket.com/article/2152083/抹茶可醫乳癌?英研究發現抹茶可令乳癌細胞休眠死去

http://www.dailymail.co.uk/health/article-6118469/Could-matcha-green-tea-used-treat-cancer.html

城中活動

2020-08-04 2:00 pm 強身健體八段錦
2020-07-18 2:00 pm (活動取消) 手語初體驗

疑難排解

會員註冊


或許你會想看
美國食物及藥物管理局(FDA)警告減肥藥沛麗婷(Belviq)可能有致癌風險 監管機構稱他們正審閱此藥物的安全性研究
美國食物及藥物管理局(FDA)警告減肥藥沛麗婷(Belviq)可能有致癌風險 監管機構稱他們正審閱此藥物的安全性研究   FDA提醒公眾減肥藥沛麗婷(Belviq)可能導致增加致癌風險 聯邦監管機構提醒公眾處方減肥藥沛麗婷[...]
轉移性膀胱癌 免疫治療增存活率 為晚期患者帶來新希望認清症狀 及早求醫
轉移性膀胱癌 免疫治療增存活率 為晚期患者帶來新希望認清症狀 及早求醫   (2020 年 1 月 6 日,香港) 膀胱癌是香港常見但容易受人忽視的癌症,每年平均約有400 宗新症,而死亡人數約 200 人,死亡率高達百分[...]
美國科學家呼籲保留兒童乳齒以備未來治療癌症之用
美國科學家呼籲保留兒童乳齒以備未來治療癌症之用     兒童乳齒原來是寶物,它含有幹細胞組織,就算脫落了10年仍然有效,而且由乳齒取得的幹細胞,比起抽骨髓簡單又無需承受痛楚。究竟幹細胞好處在哪裏﹖科學家相信乳齒的[...]
基因編輯技術CRISPR能否為癌症治療開展新一頁﹖
基因編輯技術CRISPR能否為癌症治療開展新一頁﹖     癌症並非是絕症,現今已被視作長期病,所以當醫療科技愈來愈先進,是否代表著癌症病人的存活率亦愈來愈有保障﹖最近,有醫生嘗試為3名癌症病人使用CRISPR作[...]
百濟神州實現“零的突破”!國產原研抗癌新藥提前4個月獲FDA通過
百濟神州實現“零的突破”!國產原研抗癌新藥提前4個月獲FDA通過   11月15日,美國食品藥品監督管理局(FDA)宣佈,中國企業百濟神州自主研發的抗癌新藥“澤布替尼”,以“突破性療法”身份,“優先審評”獲准上市,預計未來[...]
主動參與治療過程
主動參與治療過程 確診患癌後妳當然希望在癌細胞擴散之前盡早接受治療,這時候妳需要盡快了解哪些治療對妳更為有效和安全,然後選擇對妳最好的治療方案。妳當然應該信任妳的醫生,但妳或許希望尋求第二意見,由另一位醫生檢視妳的檢驗報告和治療方案[...]
患上乳癌後,妳要怎樣照顧自己的身體?
患上乳癌後,妳要怎樣照顧自己的身體? 治療乳癌可能是一個漫長的過程,但是在生活上和治療上都有一些方法可以助妳減少不適,讓妳能較安然和積極地渡過各個療程。 多看多問,認識妳的疾病,了解它的治療方法。 和妳的醫護團隊充分合作。 和妳的醫[...]
轉移性乳癌的治療
轉移性乳癌的治療 轉移性乳癌指癌細胞已由乳房擴散至其他器官(第 4 期),一般不適合以手術切除,故治療方法多以藥物治療為主,可能包括化療、標靶藥物或荷爾蒙治療。視乎情況亦有可能配以放射治療。 對於轉移性乳癌的治療,妳可能有聽說過所謂[...]
早期乳癌的治療
早期乳癌的治療 早期乳癌泛指腫瘤可以手術切除 (一般包括第 1-3 期),故手術是治療早期乳癌的關鍵元素,而術前及術後的輔助治療均可為妳帶來潛在益處。   術前輔助治療 又稱術前治療,即手術前給予的治療,可能包括化療、標靶[...]
HER2 型乳癌是什麼?
HER2 型乳癌是什麼? 在本港,約 20%乳癌個案是「較惡」的 HER2 型乳癌。HER2 (第二型人類表皮生長因子受體)自然地存在於乳房細胞內,是一種附在細胞表面的受體。正常細胞會製造少量的 HER2 受體,用作接收生長因子,將[...]
治療乳癌的標靶治療
治療乳癌的標靶治療 標靶藥物對特定的癌細胞有針對性,能夠識別、鎖定並針對攻擊癌細胞,不會對正常細胞造成傷害。標靶藥物可能會與化療或其他治療一起使用,以提升療效。 治療乳癌的標靶藥大致上可分為四種: 抗HER2 標靶藥物 抗血管增生藥[...]
治療乳癌的化學治療(化療)
治療乳癌的化學治療(化療) 即是利用抗癌藥物來破壞癌細胞,但同時亦會影響代謝較快的正常細胞。治療分口服和靜脈注射兩種形式,每次療程只需幾天,隨後是數星期的休息。療程的次數需視乎癌症種類及妳對藥物的反應而定。   化療主要應[...]